Precis Future Med Search

CLOSE


Instructions for Authors

  • HOME
  • AUTHOR INFORMATION
  • Instructions for Authors

Enacted December 1, 2016

The Precision and Future Medicine (Precis Future Med, P&FM) is an official publication of the Sungkyunkwan University School of Medicine. Anyone who would like to submit a manuscript is advised to carefully read the aims and scope section of this journal. Manuscripts submitted to P&FM should be prepared according to the following instructions. For issues not addressed in these instructions, the author is referred to the International Committee of Medical Journal Editors (ICMJE) “Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals” (http://www.icmje.org/recommendations/).

AIMS AND SCOPE
RESEARCH AND PUBLICATION ETHICS
COPYRIGHTS, OPEN ACCESS POLICY
MANUSCRIPT PREPARATION
SUBMISSION & PEER REVIEW PROCESS
MANUSCRIPTS ACCEPTED FOR PUBLICATION
PUBLICATION PAGE CHARGES
CONTACT INFORMATION

AIMS AND SCOPE

The aims of Precision and Future Medicine (P&FM) are to convey new messages regarding general medicine to the global community and to encourage and expedite the publication of medical discoveries, innovations, and new concepts in medicine for our beneficiaries. Thus, this journal, although it is aiming to become a general medical journal, is distinct from ordinary medical journals as it accepts and publishes new and innovative diagnostic and therapeutic information with greater priority over conventional clinical trial results. This journal will publish not only clinical papers but also translational, genomic, therapeutic, and biotechnological research papers. The journal also welcomes laboratory and animal studies on new drugs and novel medical devices and those that elucidate targetable mechanisms of human diseases. These aims and scope will be executed through various types of publications—Original Articles, Reviews, Research Methods, Analyses, Case Reports, Letters to the Editor, and Editorials. The number of case reports published will be limited for each issue. It is published four times per year: March 31, June 30, September 30, and December 31.

RESEARCH AND PUBLICATION ETHICS

The journal adheres to the ethical guidelines for research and publication described in Guidelines on Good Publication (http://publicationethics.org/resources/guidelines) and Good Publication Practice Guidelines for Medical Journals (http://kamje.or.kr/intro.php?body=publishing_ethics).

1. Authorship and Author’s Responsibility
Authorship credit should be based on (1) substantial contributions to conception and design, acquisition of data, or analysis and interpretation of data; (2) drafting the article or revising it critically for important intellectual content; and (3) final approval of the version to be published; and (4) agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Authors should meet these four conditions.
After the initial submission of a manuscript, any changes whatsoever in authorship (adding author(s), deleting author(s), or re-arranging the order of authors) must be explained by a letter to the editor from the authors concerned. This letter must be signed by all authors on the paper. Copyright assignment must be completed by every author.
The corresponding author takes primary responsibility for communication with the journal during the manuscript submission, peer review, and publication process, and typically ensures that all the journal’s administrative requirements, such as providing details of authorship, ethics committee approval, clinical trial registration documentation, and gathering conflict of interest forms and statements, are properly completed, although these duties may be delegated to one or more coauthors. The corresponding author should be available throughout the submission and peer review process to respond to editorial queries in a timely manner, and should be available to respond to critiques of the work and cooperate with any requests from the journal for data or additional information or questions about the paper even after publication. P&FM does not allow multiple corresponding authors for one article. Only one author should correspond with the editorial office and readers for one article. P&FM does accept notice of equal contribution for the first author when the study was clearly performed by co-first authors. There is no limitation on the number of authors.
2. Originality, Plagiarism, and Duplicate Publication
Submitted manuscripts must not have been previously published or be under consideration for publication elsewhere. No part of the accepted manuscript should be duplicated in any other scientific journal without the permission of the Editorial Board. Submitted manuscripts are screened for possible plagiarism or duplicate publication by Crossref Similarity Check (https://www.crossref.org/get-started/similarity-check/) upon arrival. If plagiarism or duplicate publication related to the papers of this journal is detected, the manuscripts may be rejected, the authors will be announced in the journal, and their institutions will be informed. There will also be penalties for the authors.
A letter of permission is required for any and all material that has been published previously. It is the responsibility of the author to request permission from the publisher for any material that is being reproduced. This requirement applies to text, figures, and tables published by any of the authors themselves or used from another source, unless it is in the public domain.
3. Secondary Publication
It is possible to republish manuscripts if they satisfy the conditions of secondary publication of the ICMJE Recommendations (http://www.icmje.org/urm_main.html).
4. Conflict of Interest Statement
The corresponding author must inform the editor of any potential conflicts of interest that could influence the authors’ interpretation of the data. Examples of potential conflicts of interest are financial support from or connections to pharmaceutical companies, political pressure from interest groups, and academically related issues. In particular, all sources of funding applicable to the study should be explicitly stated.
5. Registration of Clinical Trial Research
It is recommended that any research that deals with a clinical trial be registered with a primary national clinical trial registration site, such as http://cris.nih.go.kr, or other sites accredited by the World Health Organization as listed at http://www.who.int/ictrp/en/.
6. Statement of Informed Consent and IRB Approval
Copies of written informed consent and Institutional Review Board (IRB) approval for clinical research should be kept. If necessary, the editor or reviewers may request copies of these documents to resolve questions about IRB approval and study conduct. In addition, for studies conducted with human subjects, the method by which informed consent was obtained from the participants also needs to be stated in the Methods section.
7. Statement of Human and Animal Rights
All human and animal investigations must be conducted according to the principles expressed in the World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects (http://www.wma.net/en/30publications/10policies/b3/index.html).
8. Process for Managing Research and Publication Misconduct
When the journal faces suspected cases of research and publication misconduct such as redundant (duplicate) publication, plagiarism, fraudulent or fabricated data, changes in authorship, an undisclosed conflict of interest, ethical problems with a submitted manuscript, a reviewer who has appropriated an author’s idea or data, complaints against editors, and so on, the resolution process will follow the flowchart provided by the Committee on Publication Ethics (http://publicationethics.org/resources/flowcharts). The discussion and decision on the suspected cases are carried out by the editorial board.
9. Editorial Responsibilities
The editorial board will continuously work to monitor and safeguard publication ethics: guidelines for retracting articles; maintenance of the integrity of the academic record; preclusion of business needs from compromising intellectual and ethical standards; publishing corrections, clarifications, retractions, and apologies when needed; and excluding plagiarism and fraudulent data. The editors maintain the following responsibilities: responsibility and authority to reject and accept articles; avoiding any conflict of interest with respect to articles they reject or accept; promoting publication of corrections or retractions when errors are found; and preservation of the anonymity of reviewers.

COPYRIGHTS, OPEN ACCESS POLICY

1. Copyright
Copyright to all the published material is owned by Sungkyunkwan University School of Medicine. The authors should agree to the copyright transfer during the submission process. The corresponding author has a responsibility of submitting the copyright transfer agreement to the Publisher.
2. Open Access Policy
P&FM is an open access journal. Articles are distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. To use the tables or figures of P&FM in other periodicals, books or media for scholarly and educational purposes, the process of permission request to the publisher of P&FM is not necessary.
3. Deposit Policy According to Sherpa/Romeo (http://www.sherpa.ac.uk)
Author cannot archive pre-print (i.e., pre-refereeing). Author can archive post-print (i.e., final draft post-refereeing). Author can archive publisher's version/PDF.

MANUSCRIPT PREPARATION

1. General Requirements
  • • Every manuscript should be written in English.
  • • The main document with manuscript text and tables should be prepared with an MS-word.
  • • The manuscript should be double spaced on 21.6×27.9 cm (letter size) or 21.0×29.7 cm (A4) paper with 3.0 cm margins at the top, bottom, and left margins.
  • • All manuscript pages are to be numbered consecutively, beginning with the abstract as page 1. Neither the author's names nor their affiliations should appear on the manuscript pages.
  • • Use only standard abbreviations; use of nonstandard abbreviations can be confusing to readers. Avoid abbreviations in the title of the manuscript. The spelled-out abbreviation followed by the abbreviation in parenthesis should be used on first mention unless the abbreviation is a standard.
  • • The names and locations (city, state, and country only) of manufacturers of equipment and non-generic drugs should be given.
  • • When quoting from other sources, give a reference number after the author's name or at the end of the quotation.
  • • Authors should express all measurements in conventional units, with International System (SI) units.
  • • To make papers more readable and informative, mark the followings in italics.
  • - Biological name of organisms: Saccharomyces cerevisiae, E. coli

  • - Restriction enzymes and some of enzymes: EcoRI, Taq polymerase

  • - Name of genes: src, c-H-ras, myc

  • - Latin: in vivo, in vitro, in situ

  • - Centrifugation force: 100,000g

2. Reporting Guidelines for Specific Study Designs
Research reports frequently omit important information. As such, reporting guidelines have been developed for a number of study designs that some journals may ask authors to follow. Authors are encouraged to also consult the reporting guidelines relevant to their specific research design. A good source of reporting guidelines is the EQUATOR Network (http://www.equator-network.org/home/) and the United States National Library of Medicine (http://www.nlm.nih.gov/services/research_report_guide.html).
3. Original Articles
Original articles should contain the results of clinical or basic research and should be sufficiently well documented to be acceptable to critical readers. The length of the manuscript should not exceed 3,000 words, not counting the abstract, references, tables, and legends to figures and illustrations, if possible, and references should not exceed 30.
The manuscript for an original article should be organized in the following sequence: title page, abstract and keywords, main text (introduction, methods, results, discussion), acknowledgments, references, tables, figure legends, figures, and supplementary data.
• Title page: Include the following items on the title page: (1) the title of the manuscript; (2) author list (include ORCID*); (3) names of each author's institutions and an indication of each author's affiliation; (4) the name, address, telephone and fax number, and e-mail address of the corresponding author; (5) if necessary, state the source of any research funding and list of where and when the study has been presented in part elsewhere; and (6) running title of fewer than 50 characters.
*ORCID: Open researcher and contributor ID (ORCID) of all authors are recommended to be provided. To have ORCID, authors should register in the ORCID web site available from https://orcid.org/. Registration is free to every researchers in the world.
• Abstract and Keywords: The abstract should be concise, less than 250 words, and describe concisely, in a paragraph, purpose, methods, results, and conclusion of the study in a structured format. Up to 5 keywords should be listed at the bottom of abstract to be used as index terms. For the selection of keywords, refer Medical Subject Heading (MeSH, https://www.ncbi.nlm.nih.gov/mesh).
• Introduction: Briefly describe the purpose of the investigation, including relevant background information.
• Methods: Describe the research plan, the materials (or subjects), and the methods used, in that order. Explain in detail how the disease was confirmed and how subjectivity in observations was controlled. When experimental methodology is the main issue of the paper, describe the process in detail so as to recreate the experiment as closely as possible. The sources of special chemicals or reagents should be given along with the source location (name of company, city, state, and country). Methods of statistical analysis and criteria for statistical significance should be described. If the reviewers want to analyze the data to confirm the results, the raw data may be provided to the Editorial Office. Computer programs used for the statistical analysis should be stated with the name, manufacturer and the software version. Statistical results are encouraged to provide measurement error or uncertainty such as confidence intervals besides providing P-values. Ethics statement should be included in this section, as the following examples. The study protocol was approved by the Institutional Review Board of OOO Hospital (IRB No. ##-##-###). Informed consent was confirmed (or waived) by the IRB. The animal studies were performed after receiving approval of the Institutional Animal Care and Use Committee (IACUC) in OOO University (IACUC approval No. ##-##- ###). If there is no IRB number, it should be discussed with the editor during the review process.
• Results: It should be described logically according to the Methods section. Tables and figures are recommended to present the results more rapidly and easily. Do not duplicate the content of a table or a figure in the Results section. Briefly describe the core results related to the conclusion in the text when data are provided in tables or in figures. In the Results section, audio or video files are also welcomed. Supplementary results can be placed in the Appendix.
• Discussion: Observations pertaining to the results of research and other related materials should be interpreted for your readers. Emphasize new and important observations; do not merely repeat the contents of the results. Explain the meaning of the observed opinion along with its limits, and within the limits of the research results connect the conclusion to the purpose of the research. In a concluding paragraph, summarize the result and its meaning.
• Conflict of interest: State any potential conflict of interest that could influence the authors' interpretation of the data, such as financial support from or connections to pharmaceutical companies, political pressure from interest groups, or academically related issues.
• Acknowledgments: All persons who have made substantial contributions, but who have not met the criteria for authorship, are acknowledged here. All sources of funding applicable to the study should be stated here explicitly.
• References: In the text, references should be cited with Arabic numerals in brackets (e.g., [1], [2,3], [4-6]), numbered in the order cited. In the references section, the references should be numbered and listed in order of appearance in the text. List all authors if there are less than or equal to six authors. List the first six authors followed by "et al." if there are more than six authors. If an article has been published online, but has not yet been given an issue or pages, the digital object identifier (DOI) should be supplied. Journal titles should be abbreviated in the style used in Medline. Other types of references not described below should follow "Samples of Formatted References for Authors of Journal Articles" (https://www.nlm.nih.gov/bsd/uniform_requirements.html).

Journal articles:
  • 1. Lee G, Lee HY, Ko ES, Jeong WK. Radiomics and imaging genomics in precision medicine. Precis Future Med 2017;1:10-31.

  • 2. Sohn IW, Jung DH, Kim JH, Chung HS, Park JC, Shin SK, et al. Analysis of the clinicopathological characteristics of gastric cancer in extremely old patients. Cancer Res Treat. 2016 Jun 27 [Epub]. https://doi.org/10.4143/crt.2016.163.

  • 3. Vuilleumier P, Bogousslavsky J, Regli F. Infarction of the lower brainstem. Clinical, aetiological and MRI-topographical correlations. Brain 1995;118(Suppl 1):1013-25.

Book & Book chapter:
  • 3. Gordon PH, Nivatvongs S, editors. Principles and practice of surgery for the colon, rectum and anus. 3rd ed. New York(NY): Informa Healthcare; 2007.

  • 4. Meltzer PS, Kallioniemi A, Trent JM. Chromosome alterations in human solid tumors. In: Vogelstein B, Kinzler KW, editors. The genetic basis of human cancer. New York (NY): McGraw-Hill; 2002. p. 93-113.

Dissertation:
  • 5. Kang DM. Characteristics of the ionic currents in rabbit basilar arterial smooth muscle cells [dissertation]. Seoul (KR): Seoul National Univ.; 1994.

Conference paper:
  • 6. Rice AS, Brooks JW. Canabinoids and pain. In: Dostorovsky JO, Carr DB, editors. Proceedings of the 10th World Congress on Pain; 2002 Aug 17-22; San Diego, CA. Seattle (WA): IASP Press; 2003. p. 437-46.

  • 7. Basile P, Iwanicki-Caron I, Toure E, Antonietti M, Lecleire S, Di Fiore A, et al. Usefulness of circulating tumor cell detection in pancreatic adenocarcinoma diagnosis [abstract]. J Clin Oncol 2013;31(No 4_suppl):157.

Online sources:
  • 8. American Cancer Society. Cancer facts and statistics [Internet]. Atlanta (GA): American Cancer Society; c2016 [cited 2016 November 20]. Available from: http://www.cancer.org/research/cancerfactsstatistics/.

  • 9. National Cancer Information Center. Cancer incidence in Korea, 2010 [Internet]. Goyang (KR): National Cancer Information Center; 2016 [cited 2016 November 15]. Available from: http://ncc.re.kr/english/infor/kccr.jsp.

• Table: Tables are to be numbered in the order in which they are cited in the text. A table title should concisely describe the content of the table so that a reader can understand the table without referring to the text. Each table must be simple and typed on a separate page with its title. Explanatory matter is placed in footnotes below the table and not included in the heading. All non-standard abbreviations are explained in the footnotes. Footnotes should be indicated by a), b), c), d), ... Statistical measures such as SD or SE should be identified. Vertical rules and horizontal rules between entries should be omitted.
• Figure & legends for illustrations: Figures must be submitted as separate files saved in JPEG, TIFF, GIF, EPS, or PPT format (do not embedded the figures in the Microsoft Word manuscript file). Other formats of figure are negotiable. Contact editorial office for other formats. All images should exceed the following image resolutions: line art (an image composed of lines and text) 1,000 dpi; halftone (a continuous tone photograph, which contains no text) 300 dpi; or combination (line art and halftone) 600 dpi.
  Photographs of recognizable persons should be accompanied by a signed release from the person in the photograph or an appropriate legal guardian authorizing publication. Written permission should be obtained for the use of all previously published illustrations (and copies of permission letters should be included).
  Figures should be numbered, using Arabic numerals, in the order in which they are cited. In the case of multiple prints bearing the same number, use English letters after the numerals to indicate the correct order. (ex) Fig. 1A, Fig. 1B, C.
  If any tables or figures are moved or modified from other papers, authors should obtain permission through the Copyright Clearance Center https://www.copyright.com/ or from the individual publisher if the materials are not included in open access journal published according to the Creative Commons license. If tables or figures are from open access journal, simply verify the source of the journal precisely in the footnote. Please note that a free access journal is different from that of open access; therefore, it is necessary to obtain permission from the publisher of the free access journal for using tables or figures from these sources.
• Supplementary data: If there are any supplementary materials to help the understanding of readers or too great amount data to be included in the main text, it may be placed as supplementary data. Supplementary data should be as concise as possible and must be related to the main conclusion of the paper. Supplementary data can include electronic files of high resolution images, background datasets, video materials, animations and more. Supplementary data will be published online alongside the electronic version of article. Video data files can be submitted in the same way as a figure or table by referring to the video or animation content. Since video and animation cannot be embedded in the print version, authors have to provide text for both the electronic and the print version for the portions of the article that refer to this content.
4. Reviews
Reviews are comprehensive analyses of specific topics. They are usually solicited by the Editor, but we will consider unsolicited material. Please send us a Presubmission Inquiry before writing a review article. All review articles undergo the same review process as other types of article prior to acceptance. They are organized as follows: title page, abstract and keywords, introduction, main text, conclusion, acknowledgments, references, tables, figure legends, and figures. Reviews have no restrictions on word count or the number of figures and tables. However, authors should eliminate redundancy, emphasize the central message, and provide only the data necessary to convey that message. The approximate length should be 3,000 to 5,000 words. There should be an unstructured abstract equal to or less than 200 words. References should not exceed 200.
5. Research Methods
Research methods report original work on methodological issues. These present methodological approaches, modifications of existing methods, or discussions of quantitative and data analytic approaches. General rules for original articles apply to this type.
6. Analyses
Analyses do not report original data, but are review-based reports including a new analysis of existing data (typically large biological data sets such as genomes, microarrays and proteomics) that lead to a novel, exciting and arresting conclusion. These are limited to 3,000 words, not counting the abstract, references, tables, and legends to figures and illustrations, if possible, and references should not exceed 30. A maximum of 5 figures including tables is allowed.
7. Case Reports
Case reports will be published only in exceptional circumstances, when they illustrate a rare occurrence of clinical importance. These manuscripts should be organized in the following sequence: title page, abstract and keywords, introduction, case report(s), discussion, acknowledgments, references, tables, figure legends, and figures. Case reports are limited to 1,500 words, not counting the abstract, references, tables, and legends to figures and illustrations, if possible, and references should not exceed 10. A maximum of 5 figures including tables is allowed.
8. Letters to the Editor
Letters to the editor may be in response to a published article, or a short, free-standing piece expressing an opinion. If the letters to the editor is in response to a published article, the Editor-in-Chief may choose to invite the article’s authors to write a reply. No abstraction is required. The letters to the editor should be 1,000 words or less (excluding references and figure legends) with a maximum of 5 references. A maximum of 2 figures including tables is allowed.
9. Editorials
Editorials are invited by the editor and should be commentaries on articles in the current issue. Editorial topics could include active areas of research, fresh insights, and debates in all fields considered to be of interest to P&FM readers. Editorials should not exceed 1,000 words, excluding references, tables, and figures. References should not exceed 5. A maximum of 3 figures including tables is allowed.
10. Other Publication Types
Other publication types may be accepted. The recommended format should be discussed with the Editorial Board.
Table 1. Specification for publication types
Type of article Abstract (word) Text (word)a) Reference Table & figure
Original article Structured, 250 3,000 30b) 7
Review article 200 3,000–5,000 200 NL
Research method Structured, 250 3,000 30 7
Analysis 200 3,000 30 5
Case report 150 1,500 10 5
Letter to the editor NR 1,000 5 2
Editorial NR 1,000 5 3

Any article longer than these limits should be discussed with the editor.
NL, not limited; NR, not required.
a)Maximum number of words is exclusive of the abstract, references, and figure legends;
b)Except meta-analyses or systematic reviews.

SUBMISSION & PEER REVIEW PROCESS

1. Submission
•Online submission: All manuscripts should be submitted online via the journal’s website (https://mc04.manuscriptcentral.com/pfm/) by the corresponding author. Once you have logged into your account, on-line system will lead you through the submission process in a step-by-step orderly process. Submission instructions are available at the website. All articles submitted to the journal must comply with these instructions. Failure to do so will result in return of the manuscript and possible delay in publication.
• Author's checklist: You will be first requested to confirm the Author's Checklist. Before submitting new manuscript, please ensure every point listed in the Author's Checklist (http://pfmjournal.org/authors/checklist.php).
• Document forms: Before you log in the online submission system, it is great helpful to prepare the following documents because you will be asked to upload these documents during the electronic submission.
  • Author statement forms
  • Cover letter: A Cover Letter must be included indicating the address, telephone and fax numbers, and E-mail address of the corresponding author.
  • English proof-reading (non-obligatory): Although it is not an obligatory demand, author can provide English Proof-Reading which certificates the manuscript is edited by English proofreading services.
2. Peer Review Process
• Review process: P&FM reviews all manuscripts received. A manuscripts first reviewed for its format and then sent to the two most relevant investigators of the field. In addition, if deemed necessary, a review of statistics may be requested. Authors' names and affiliations are removed during peer review. The acceptance criteria for all papers are based on the quality and originality of the research and its clinical and scientific significance. Acceptance of the manuscript is decided based on the critiques and recommended decision of the referees. An initial decision will normally be made within 2 weeks of receipt of a manuscript, and reviewers’ comments are sent to the corresponding authors by e-mail. Revised manuscripts must be submitted online by the corresponding author. The corresponding author must indicate the alterations that have been made in response to the referees’ comments item by item. Failure to resubmit the revised manuscript within 4 weeks of the editorial decision is regarded as a withdrawal. A final decision on acceptance for publication or rejection for publication is forwarded to the corresponding author from the Editorial Office.
• Appeals of decisions: Any appeal against the editorial decision must be made within 2 weeks of the date of the decision letter. Authors who wish to appeal a decision should contact the Editor-in-Chief, explaining in detail their reasons for the appeal. All appeals will be discussed with at least one other associate editors. If those associate editors do not agree, the appeal will be discussed at a full editorial meeting. P&FM does not consider second appeals.

MANUSCRIPT ACCEPTED FOR PUBLICATION

1. Final Version
After the paper has been accepted for publication, the author(s) should submit the final version of the manuscript. The names and affiliations of the authors should be double-checked and if the originally submitted image files were of poor resolution, higher resolution image files should be submitted at this time. The EPS, JPG, PPT, TIF formats are preferred for submission of digital files of photographic images. Symbols (e.g., circles, triangles, squares), letters (e.g., words, abbreviations), and numbers should be large enough to be legible on reduction to the journal’s column widths. All symbols must be defined in the figure caption. If references, tables, or figures are moved, added, or deleted during the revision process, renumber them to reflect such changes so that all tables, references and figures are cited in numeric order.
2. Manuscript Corrections
Before publication, the manuscript editor will correct the manuscript such that it meets the standard publication format. The author(s) must respond within 2 days when the manuscript editor contacts the author for revisions. If the response is delayed, the manuscript’s publication may be postponed to the next issue.
3. Gallery Proof
The author(s) will receive the final version of the manuscript as a PDF file. Upon receipt, within 2 days, the editorial office (or printing office) must be notified of any errors found in the file. Any errors found after this time are the responsibility of the author(s) and will have to be corrected as an erratum.
4. Errata, Corrigenda
For correcting errors in published articles, the corresponding author should contact the Journal's Editorial Office with a detailed description of the correction. Corrections that affect profoundly the interpretation or conclusions of the article will be reviewed by the Editors. Corrections will be published as Corrigenda (corrections of author's errors) or Errata (corrections of publisher's errors) in a later issue of the Journal.

PUBLICATION PAGE CHARGES

There are no author submission fees or other publication-related charges. All cost for the publication process is supported by the Publisher. P&FM is a so-called platinum open access journal which does not charge author fees.

CONTACT INFORMATION

Editor-in-Chief: Oh Young Bang
Department of Neurology, Sungkyunkwan University School of Medicine, Seoul 06351, Korea
E-mail: ohyoung.bang@samsung.com

Editor-in-Chief: Tong Mook Kang
Department of Physiology, Sungkyunkwan University School of Medicine, Suwon 16419, Korea
E-mail: tongmkang@skku.edu

Editorial Office:
Sungkyunkwan University School of Medicine
81 Irwon-ro, Gangnam-gu, Seoul 06351, Korea
Tel: +82-2-3410-6939,   Fax: +82-2-2148-9919
E-mail: pfmjournal@skku.edu



ABOUT
ARTICLES

Browse all articles >

ISSUES
TOPICS

Browse all articles >

AUTHOR
INFORMATION
Editorial Office
Sungkyunkwan University School of Medicine
81 Irwon-ro, Gangnam-gu, Seoul 06351, Korea
Tel: +82-2-3410-6939    Fax: +82-2-2148-9919    E-mail: pfmjournal@skku.edu                

Copyright © 2017 by Sungkyunkwan University School of Medicine. All rights reserved.

Developed in M2community

Close layer
prev next